AccessAfrica 2 aims to improve the ethical review and regulatory capacity for clinical trials in two Sub-Saharan African (SSA) countries.
It will specifically focus on the review and oversight of reported adverse events during clinical trials, enhance the efficiencies of the National Ethics Committees (NECs) and National Regulatory Authorities (NRAs), and equip them with the skills and knowledge necessary for improved operations during outbreaks and epidemics
The project is coordinated by Prof. Rosemarie de La Cruz Bernabe from the Centre of Medical Ethics at the University of Oslo and implemented by four institutions in Uganda and Ethiopia.
Read more about the project on: www.accessafrica.uio.no
Project Start and Finish
The project started on July 1, 2023, and it will run for 36 months.
Financing
AccessAfrica 2 is a funded EU and Global Health EDCTP3 project.
